(Guest Lecture): Balancing Today with Tomorrow’s Opportunity | MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma

(Guest Lecture): A Discussion of Two Case Studies | MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma

(Guest Lecture): An Increasing Arsenal of Therapeutic Options | MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma

(Guest Lecture): The Ever-Changing Landscape of Treatment | MCRT Webcast: Why Physicians Are Optimistic About Newly Diagnosed Myeloma

What chromosomal abnormalities are considered high-risk, standard risk?

What is the definition of high-risk multiple myeloma (HRMM)?

Do all my myeloma cells same chromosomal mutations? What is clonal heterogeneity? (Part 2)

What is a genetic signature?

Why is myeloma hard to treat? What is meant by a signaling pathway?

What is BRAF, RAS (K RAS, N RAS)?